Louis Denis Selected Research

gusacitinib

1/2023	Oral spleen tyrosine kinase/Janus Kinase inhibitor gusacitinib for the treatment of chronic hand eczema: Results of a randomized phase 2 study.
10/2019	Oral Janus kinase/SYK inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in patients with atopic dermatitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Louis Denis Research Topics

Disease

7	Neoplasms (Cancer) 01/2021 - 11/2002
5	Prostatic Neoplasms (Prostate Cancer) 11/2018 - 10/2009
2	Colorectal Neoplasms (Colorectal Cancer) 08/2006 - 08/2004
1	Eczema 01/2023
1	Adenocarcinoma of Lung 05/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2022
1	Melanoma (Melanoma, Malignant) 01/2021
1	Inflammation (Inflammations) 10/2019
1	Pruritus (Itching) 10/2019
1	Atopic Dermatitis (Atopic Eczema) 10/2019
1	Asthenia 02/2007
1	Diarrhea 02/2007
1	Embolism (Embolus) 02/2007
1	Exanthema (Rash) 02/2007
1	Hyperbilirubinemia 02/2007
1	Cardiomyopathies (Cardiomyopathy) 02/2007
1	Nausea 02/2007
1	Thrombocytopenia (Thrombopenia) 02/2007
1	Multiple Myeloma 12/2004
1	Hematologic Neoplasms (Hematological Malignancy) 12/2004
1	Osteosarcoma (Osteogenic Sarcoma) 01/2003
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2003
1	Adenocarcinoma 01/2003
1	Carcinoma (Carcinomatosis) 11/2002

Drug/Important Bio-Agent (IBA)

4	Prostate-Specific Antigen (Semenogelase)IBA 02/2018 - 11/2002
3	Irinotecan (Camptosar)FDA LinkGeneric 08/2006 - 08/2004
2	gusacitinibIBA 01/2023 - 10/2019
2	Topoisomerase I InhibitorsIBA 08/2006 - 12/2004
1	Syk KinaseIBA 01/2023
1	Janus Kinase InhibitorsIBA 01/2023
1	defactinibIBA 05/2022
1	Codon (Codons)IBA 05/2022
1	Immune Checkpoint InhibitorsIBA 05/2022
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021
1	ASN007IBA 01/2021
1	Janus KinasesIBA 10/2019
1	Biomarkers (Surrogate Marker)IBA 10/2019
1	Androgen Receptors (Androgen Receptor)IBA 11/2018
1	Androgen Antagonists (Antiandrogens)IBA 11/2018
1	enzalutamideIBA 11/2018
1	cabazitaxel FDA Link 04/2011
1	Testosterone (Sustanon)FDA Link 04/2011
1	Tyrosine Kinase InhibitorsIBA 02/2007
1	Alanine Transaminase (SGPT)IBA 02/2007
1	Transaminases (Aminotransferases)IBA 02/2007
1	2- methoxy- N- (3- (4- ((3- methyl- 4- ((6- methyl- 3- pyridinyl)oxy)phenyl)amino)- 6- quinazolinyl)- 2- propenyl)acetamideIBA 02/2007
1	PowdersIBA 08/2006
1	Capsules (Microcapsules)IBA 08/2006
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 12/2004
1	Phosphotransferases (Kinase)IBA 12/2004
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 12/2004
1	CaspasesIBA 12/2004
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2003
1	PlatinumIBA 01/2003
1	CamptothecinIBA 01/2003
1	Etoposide (VP 16)FDA LinkGeneric 01/2003

Therapy/Procedure

2	Castration 11/2018 - 04/2011
2	Therapeutics 12/2004 - 11/2002
1	Drug Therapy (Chemotherapy) 05/2022